Naoki Nakayama
Department of Metabolic Disorders
Amgen
One Amgen Center Drive
Thousand Oaks
USA
Name/email consistency: high
- A novel chordin-like BMP inhibitor, CHL2, expressed preferentially in chondrocytes of developing cartilage and osteoarthritic joint cartilage. Nakayama, N., Han, C.Y., Cam, L., Lee, J.I., Pretorius, J., Fisher, S., Rosenfeld, R., Scully, S., Nishinakamura, R., Duryea, D., Van, G., Bolon, B., Yokota, T., Zhang, K. Development (2004)